Welcome to the Running newsletter! Every Saturday morning, we email runners with news, advice and some motivation to help you get up and running. Sign up here to get it in your inbox. On Tuesday, the running world lost a good one. Gabriele Grunewald, a track champion, died of complications from cancer. She was 32.… Read More »
FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin Print this page THOUSAND OAKS, Calif., June 13, 2019 /PRNewswire/ — Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Kanjinti (trastuzumab-anns) for all approved indications of the reference product, Herceptin® (trastuzumab): for the treatment of HER2-overexpressing adjuvant… Read More »
A new study of healthcare innovation shows progress toward new approaches to care delivery could use a nudge. The report, entitled, “Trends for Scaling Innovation in Health Care,” was based on a survey of 29 health system executives from 28 unique health systems, and found that while many health systems and their affiliated health plans… Read More »
Older African Americans with mild cognitive impairment (MCI) who got help setting goals to be more socially, physically, or cognitively active had slower memory decline than those who did not receive such help, concludes an NIA-funded study published Sept. 10 in JAMA Neurology. The results point to a possible way to reduce dementia risk in… Read More »